{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:27:12Z","timestamp":1783312032837,"version":"3.54.6"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T00:00:00Z","timestamp":1553126400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s12264-019-00367-8","type":"journal-article","created":{"date-parts":[[2019,3,21]],"date-time":"2019-03-21T09:10:20Z","timestamp":1553159420000},"page":"661-672","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Antidepressant-Like Action of Single Facial Injection of Botulinum Neurotoxin A is Associated with Augmented 5-HT Levels and BDNF\/ERK\/CREB Pathways in Mouse Brain"],"prefix":"10.1007","volume":"35","author":[{"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cun-Jin","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Lin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei-Fang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Yan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weifeng","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9152-5264","authenticated-orcid":false,"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,21]]},"reference":[{"key":"367_CR1","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopsych.2017.08.008","volume":"83","author":"E Scifo","year":"2017","unstructured":"Scifo E, Pabba M, Kapadia F, Ma T, Lewis DA, Tseng GC, et al. Sustained Molecular Pathology Across Episodes and Remission in Major Depressive Disorder. Biol Psychiatry 2017, 83:81\u201389.","journal-title":"Biol Psychiatry"},{"key":"367_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1056\/NEJMra073096","volume":"358","author":"RH Belmaker","year":"2008","unstructured":"Belmaker RH, Agam G. Major depressive disorder. N Engl J Med 2008, 358: 55\u201368.","journal-title":"N Engl J Med"},{"key":"367_CR3","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S0140-6736(11)60602-8","volume":"379","author":"DJ Kupfer","year":"2012","unstructured":"Kupfer DJ, Frank E, Phillips ML. Major depressive disorder: new clinical, neurobiological, and treatment perspectives. Lancet 2012, 379: 1045\u20131055.","journal-title":"Lancet"},{"key":"367_CR4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1056\/NEJMra050730","volume":"353","author":"JJ Mann","year":"2005","unstructured":"Mann JJ. The medical management of depression. N Engl J Med 2005, 353: 1819\u20131834.","journal-title":"N Engl J Med"},{"key":"367_CR5","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/nature17998","volume":"533","author":"P Zanos","year":"2016","unstructured":"Zanos P, Moaddel R, Morris PJ, Georgiou P, Fischell J, Elmer GI, et al. NMDAR inhibition-independent antidepressant actions of ketamine metabolites. Nature 2016, 533: 481\u2013486.","journal-title":"Nature"},{"key":"367_CR6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature25509","volume":"554","author":"Y Yang","year":"2018","unstructured":"Yang Y, Cui Y, Sang K, Dong Y, Ni Z, Ma S, et al. Ketamine blocks bursting in the lateral habenula to rapidly relieve depression. Nature 2018, 554: 317\u2013322.","journal-title":"Nature"},{"key":"367_CR7","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature10130","volume":"475","author":"AE Autry","year":"2011","unstructured":"Autry AE, Adachi M, Nosyreva E, Na ES, Los MF, Cheng PF, et al. NMDA receptor blockade at rest triggers rapid behavioural antidepressant responses. Nature 2011, 475: 91\u201395.","journal-title":"Nature"},{"key":"367_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s40263-018-0492-x","volume":"32","author":"P Zanos","year":"2018","unstructured":"Zanos P, Thompson SM, Duman RS, Zarate CA, Jr., Gould TD. Convergent mechanisms underlying rapid antidepressant action. CNS Drugs 2018, 32: 197\u2013227.","journal-title":"CNS Drugs"},{"key":"367_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s12264-015-0009-2","volume":"32","author":"H Akhtar","year":"2016","unstructured":"Akhtar H, Bukhari F, Nazir M, Anwar MN, Shahzad A. Therapeutic efficacy of neurostimulation for depression: techniques, current modalities, and future challenges. Neurosci Bull 2016, 32: 115\u2013126.","journal-title":"Neurosci Bull"},{"key":"367_CR10","first-page":"283","volume":"4","author":"BE Lacy","year":"2008","unstructured":"Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future? Gastroenterol Hepatol (N Y) 2008, 4: 283\u2013295.","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"367_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.jaad.2005.06.011","volume":"53","author":"TR Cote","year":"2005","unstructured":"Cote TR, Mohan AK, Polder JA, Walton MK, Braun MM. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol 2005, 53: 407\u2013415.","journal-title":"J Am Acad Dermatol"},{"key":"367_CR12","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.resmic.2014.10.010","volume":"166","author":"AT Carter","year":"2015","unstructured":"Carter AT, Peck MW. Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II. Res Microbiol 2015, 166: 303\u2013317.","journal-title":"Res Microbiol"},{"key":"367_CR13","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1016\/j.bbapap.2016.09.001","volume":"1864","author":"BV Ayyar","year":"2016","unstructured":"Ayyar BV, Atassi MZ. Effects of membrane properties on the binding activities of the HN and HC heavy-chain domains of botulinum neurotoxin A. Biochim Biophys Acta 2016, 1864: 1678\u20131685.","journal-title":"Biochim Biophys Acta"},{"key":"367_CR14","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrmicro3295","volume":"12","author":"O Rossetto","year":"2014","unstructured":"Rossetto O, Pirazzini M, Montecucco C. Botulinum neurotoxins: genetic, structural and mechanistic insights. Nat Rev Microbiol 2014, 12: 535\u2013549.","journal-title":"Nat Rev Microbiol"},{"key":"367_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/bju.13163","volume":"117","author":"D Papagiannopoulou","year":"2016","unstructured":"Papagiannopoulou D, Vardouli L, Dimitriadis F, Apostolidis A. Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats. BJU Int 2016, 117: 697\u2013704.","journal-title":"BJU Int"},{"key":"367_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jebdp.2017.06.006","volume":"17","author":"YW Chen","year":"2017","unstructured":"Chen YW, Chuang SK. Botulinum Toxin A might be an alternative or adjunct therapy for the treatment of trigeminal and postherpetic neuralgia. J Evid Based Dent Pract 2017, 17: 259\u2013261.","journal-title":"J Evid Based Dent Pract"},{"key":"367_CR17","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s11910-014-0511-3","volume":"15","author":"R Mills","year":"2015","unstructured":"Mills R, Bahroo L, Pagan F. An update on the use of botulinum toxin therapy in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 2015, 15: 511.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"367_CR18","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1111\/bph.12763","volume":"171","author":"R Ramachandran","year":"2014","unstructured":"Ramachandran R, Yaksh TL. Therapeutic use of botulinum toxin in migraine: mechanisms of action. Br J Pharmacol 2014, 171: 4177\u20134192.","journal-title":"Br J Pharmacol"},{"key":"367_CR19","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S1474-4422(16)00017-X","volume":"15","author":"N Attal","year":"2016","unstructured":"Attal N, de Andrade DC, Adam F, Ranoux D, Teixeira MJ, Galhardoni R, et al. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial. Lancet Neurol 2016, 15: 555\u2013565.","journal-title":"Lancet Neurol"},{"key":"367_CR20","doi-asserted-by":"publisher","first-page":"837","DOI":"10.4088\/JCP.13m08845","volume":"75","author":"M Magid","year":"2014","unstructured":"Magid M, Reichenberg JS, Poth PE, Robertson HT, LaViolette AK, Kruger TH, et al. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2014, 75: 837\u2013844.","journal-title":"J Clin Psychiatry"},{"key":"367_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0035-1559621","volume":"48","author":"M Magid","year":"2015","unstructured":"Magid M, Finzi E, Kruger TH, Robertson HT, Keeling BH, Jung S, et al. Treating depression with botulinum toxin: a pooled analysis of randomized controlled trials. Pharmacopsychiatry 2015, 48: 205\u2013210.","journal-title":"Pharmacopsychiatry"},{"key":"367_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2013.11.006","volume":"52","author":"E Finzi","year":"2014","unstructured":"Finzi E, Rosenthal NE. Treatment of depression with onabotulinumtoxinA: a randomized, double-blind, placebo controlled trial. J Psychiatr Res 2014, 52: 1\u20136.","journal-title":"J Psychiatr Res"},{"key":"367_CR23","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.1007\/s12035-016-9983-2","volume":"54","author":"Z Xu","year":"2017","unstructured":"Xu Z, Guo X, Yang Y, Tucker D, Lu Y, Xin N, et al. Low-level laser irradiation improves depression-like behaviors in mice. Mol Neurobiol 2017, 54: 4551\u20134559.","journal-title":"Mol Neurobiol"},{"key":"367_CR24","doi-asserted-by":"publisher","first-page":"16751","DOI":"10.1038\/srep16751","volume":"5","author":"G Zhang","year":"2015","unstructured":"Zhang G, Chen L, Yang L, Hua X, Zhou B, Miao Z, et al. Combined use of spatial restraint stress and middle cerebral artery occlusion is a novel model of post-stroke depression in mice. Sci Rep 2015, 5: 16751.","journal-title":"Sci Rep"},{"key":"367_CR25","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 1977, 229: 327\u2013336.","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"367_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 1985, 85: 367-370.","journal-title":"Psychopharmacology (Berl)"},{"key":"367_CR27","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41596-018-0011-z","volume":"13","author":"MY Liu","year":"2018","unstructured":"Liu MY, Yin CY, Zhu LJ, Zhu XH, Xu C, Luo CX, et al. Sucrose preference test for measurement of stress-induced anhedonia in mice. Nat Protoc 2018, 13:1686\u20131698.","journal-title":"Nat Protoc"},{"key":"367_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3389\/fnmol.2018.00120","volume":"11","author":"B Wang","year":"2018","unstructured":"Wang B, Su CJ, Liu TT, Zhou Y, Feng Y, Huang Y, et al. The neuroprotection of low-dose morphine in cellular and animal models of Parkinson\u2019s disease through ameliorating endoplasmic reticulum (ER) stress and activating autophagy. Front Mol Neurosci 2018, 11: 120.","journal-title":"Front Mol Neurosci"},{"key":"367_CR29","doi-asserted-by":"publisher","first-page":"36286","DOI":"10.1038\/srep36286","volume":"6","author":"B Tian","year":"2016","unstructured":"Tian B, Wang XL, Huang Y, Chen LH, Cheng RX, Zhou FM, et al. Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats. Sci Rep 2016, 6: 36286.","journal-title":"Sci Rep"},{"key":"367_CR30","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.neubiorev.2014.08.017","volume":"47","author":"M Ghasemi","year":"2014","unstructured":"Ghasemi M, Phillips C, Trillo L, De Miguel Z, Das D, Salehi A. The role of NMDA receptors in the pathophysiology and treatment of mood disorders. Neurosci Biobehav Rev 2014, 47: 336\u2013358.","journal-title":"Neurosci Biobehav Rev"},{"key":"367_CR31","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.2174\/1381612819666140110120435","volume":"20","author":"YH Dang","year":"2014","unstructured":"Dang YH, Ma XC, Zhang JC, Ren Q, Wu J, Gao CG, et al. Targeting of NMDA receptors in the treatment of major depression. Curr Pharm Des 2014, 20: 5151\u20135159.","journal-title":"Curr Pharm Des"},{"issue":"Suppl 2","key":"367_CR32","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4088\/JCP.12084su1c.04","volume":"74","author":"P Blier","year":"2013","unstructured":"Blier P. Neurotransmitter targeting in the treatment of depression. J Clin Psychiatry 2013, 74 Suppl 2: 19\u201324.","journal-title":"J Clin Psychiatry"},{"key":"367_CR33","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3389\/fpsyt.2017.00308","volume":"8","author":"T Kishi","year":"2017","unstructured":"Kishi T, Yoshimura R, Ikuta T, Iwata N. Brain-derived neurotrophic factor and major depressive disorder: evidence from meta-analyses. Front Psychiatry 2017, 8: 308.","journal-title":"Front Psychiatry"},{"key":"367_CR34","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/mp.2013.105","volume":"19","author":"ML Molendijk","year":"2014","unstructured":"Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (n=9484). Mol Psychiatry 2014, 19: 791\u2013800.","journal-title":"Mol Psychiatry"},{"key":"367_CR35","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1503\/jpn.130169","volume":"39","author":"LT Yi","year":"2014","unstructured":"Yi LT, Li J, Liu BB, Luo L, Liu Q, Geng D. BDNF-ERK-CREB signalling mediates the role of miR-132 in the regulation of the effects of oleanolic acid in male mice. J Psychiatry Neurosci 2014, 39: 348\u2013359.","journal-title":"J Psychiatry Neurosci"},{"issue":"171\u2013173","key":"367_CR36","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1016\/j.jaad.2015.08.051","volume":"74","author":"JS Reichenberg","year":"2016","unstructured":"Reichenberg JS, Hauptman AJ, Robertson HT, Finzi E, Kruger TH, Wollmer MA, et al. Botulinum toxin for depression: Does patient appearance matter? J Am Acad Dermatol 2016, 74: 171\u2013173 e171.","journal-title":"J Am Acad Dermatol"},{"key":"367_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/2045-5380-4-11","volume":"4","author":"MJ Kim","year":"2014","unstructured":"Kim MJ, Neta M, Davis FC, Ruberry EJ, Dinescu D, Heatherton TF, et al. Botulinum toxin-induced facial muscle paralysis affects amygdala responses to the perception of emotional expressions: preliminary findings from an A-B-A design. Biol Mood Anxiety Disord 2014, 4: 11.","journal-title":"Biol Mood Anxiety Disord"},{"key":"367_CR38","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008, 455: 894\u2013902.","journal-title":"Nature"},{"key":"367_CR39","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s12264-015-1548-2","volume":"31","author":"J Jia","year":"2015","unstructured":"Jia J, Le W. Molecular network of neuronal autophagy in the pathophysiology and treatment of depression. Neurosci Bull 2015, 31: 427\u2013434.","journal-title":"Neurosci Bull"},{"key":"367_CR40","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1038\/tp.2016.130","volume":"6","author":"BR Godlewska","year":"2016","unstructured":"Godlewska BR, Browning M, Norbury R, Cowen PJ, Harmer CJ. Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression. Transl Psychiatry 2016, 6: e957.","journal-title":"Transl Psychiatry"},{"key":"367_CR41","doi-asserted-by":"crossref","first-page":"11","DOI":"10.31887\/DCNS.2014.16.1\/rduman","volume":"16","author":"RS Duman","year":"2014","unstructured":"Duman RS. Pathophysiology of depression and innovative treatments: remodeling glutamatergic synaptic connections. Dialogues Clin Neurosci 2014, 16: 11\u201327.","journal-title":"Dialogues Clin Neurosci"},{"key":"367_CR42","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nrd.2017.16","volume":"16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ. Targeting glutamate signalling in depression: progress and prospects. Nat Rev Drug Discov 2017, 16: 472\u2013486.","journal-title":"Nat Rev Drug Discov"},{"key":"367_CR43","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.pnpbp.2008.10.005","volume":"33","author":"AM Feyissa","year":"2009","unstructured":"Feyissa AM, Chandran A, Stockmeier CA, Karolewicz B. Reduced levels of NR2A and NR2B subunits of NMDA receptor and PSD-95 in the prefrontal cortex in major depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33: 70\u201375.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"367_CR44","doi-asserted-by":"publisher","first-page":"13573","DOI":"10.1038\/srep13573","volume":"5","author":"J Tang","year":"2015","unstructured":"Tang J, Xue W, Xia B, Ren L, Tao W, Chen C, et al. Involvement of normalized NMDA receptor and mTOR-related signaling in rapid antidepressant effects of Yueju and ketamine on chronically stressed mice. Sci Rep 2015, 5: 13573.","journal-title":"Sci Rep"},{"key":"367_CR45","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1460-9568.2011.07750.x","volume":"34","author":"YA Lee","year":"2011","unstructured":"Lee YA, Goto Y. Chronic stress modulation of prefrontal cortical NMDA receptor expression disrupts limbic structure-prefrontal cortex interaction. Eur J Neurosci 2011, 34: 426\u2013436.","journal-title":"Eur J Neurosci"},{"key":"367_CR46","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1093\/brain\/awq179","volume":"133","author":"RA Linker","year":"2010","unstructured":"Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 2010, 133: 2248\u20132263.","journal-title":"Brain"},{"key":"367_CR47","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1007\/s11064-016-2039-1","volume":"41","author":"R Maqsood","year":"2016","unstructured":"Maqsood R, Stone TW. The Gut-Brain Axis, BDNF, NMDA and CNS Disorders. Neurochem Res 2016, 41: 2819\u20132835.","journal-title":"Neurochem Res"},{"key":"367_CR48","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/bs.vh.2016.10.004","volume":"104","author":"G Leal","year":"2017","unstructured":"Leal G, Bramham CR, Duarte CB. BDNF and hippocampal synaptic plasticity. Vitam Horm 2017, 104: 153\u2013195.","journal-title":"Vitam Horm"},{"key":"367_CR49","doi-asserted-by":"crossref","unstructured":"Bekinschtein P, Cammarota M, Medina JH. BDNF and memory processing. Neuropharmacology 2014, 76 Pt C: 677\u2013683.","DOI":"10.1016\/j.neuropharm.2013.04.024"},{"key":"367_CR50","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1111\/ejn.12725","volume":"40","author":"F Guo","year":"2014","unstructured":"Guo F, Zhang Q, Zhang B, Fu Z, Wu B, Huang C, et al. Burst-firing patterns in the prefrontal cortex underlying the neuronal mechanisms of depression probed by antidepressants. Eur J Neurosci 2014, 40: 3538\u20133547.","journal-title":"Eur J Neurosci"},{"key":"367_CR51","doi-asserted-by":"publisher","first-page":"537265","DOI":"10.1155\/2013\/537265","volume":"2013","author":"F Pilar-Cuellar","year":"2013","unstructured":"Pilar-Cuellar F, Vidal R, Diaz A, Castro E, dos Anjos S, Pascual-Brazo J, et al. Neural plasticity and proliferation in the generation of antidepressant effects: hippocampal implication. Neural Plast 2013, 2013: 537265.","journal-title":"Neural Plast"},{"key":"367_CR52","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.biopsych.2017.06.017","volume":"83","author":"S Ghosal","year":"2017","unstructured":"Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, et al. Activity-dependent brain-derived neurotrophic factor release is required for the rapid antidepressant actions of scopolamine. Biol Psychiatry 2017, 83:29\u201337.","journal-title":"Biol Psychiatry"},{"key":"367_CR53","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12264-017-0189-z","volume":"34","author":"K Li","year":"2018","unstructured":"Li K, Shen S, Ji YT, Li XY, Zhang LS, Wang XD. Melatonin augments the effects of fluoxetine on depression-like behavior and hippocampal BDNF-TrkB signaling. Neurosci Bull 2018, 34: 303\u2013311.","journal-title":"Neurosci Bull"},{"key":"367_CR54","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/jnc.13977","volume":"141","author":"KI Ohta","year":"2017","unstructured":"Ohta KI, Suzuki S, Warita K, Kaji T, Kusaka T, Miki T. Prolonged maternal separation attenuates BDNF-ERK signaling correlated with spine formation in the hippocampus during early brain development. J Neurochem 2017, 141: 179\u2013194.","journal-title":"J Neurochem"},{"key":"367_CR55","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.brainresbull.2016.01.002","volume":"121","author":"S Lee","year":"2016","unstructured":"Lee S, Yang M, Kim J, Son Y, Kim J, Kang S, et al. Involvement of BDNF\/ERK signaling in spontaneous recovery from trimethyltin-induced hippocampal neurotoxicity in mice. Brain Res Bull 2016, 121: 48\u201358.","journal-title":"Brain Res Bull"},{"key":"367_CR56","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.euroneuro.2017.03.005","volume":"27","author":"R Einoch","year":"2017","unstructured":"Einoch R, Weinreb O, Mandiuk N, Youdim MBH, Bilker W, Silver H. The involvement of BDNF-CREB signaling pathways in the pharmacological mechanism of combined SSRI- antipsychotic treatment in schizophrenia. Eur Neuropsychopharmacol 2017, 27: 470\u2013483.","journal-title":"Eur Neuropsychopharmacol"},{"key":"367_CR57","doi-asserted-by":"publisher","first-page":"e1285383","DOI":"10.1080\/23262133.2017.1285383","volume":"4","author":"S Gascon","year":"2017","unstructured":"Gascon S, Ortega F, Gotz M. Transient CREB-mediated transcription is key in direct neuronal reprogramming. Neurogenesis (Austin) 2017, 4: e1285383.","journal-title":"Neurogenesis (Austin)"},{"key":"367_CR58","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.psyneuen.2015.08.028","volume":"62","author":"ML Molendijk","year":"2015","unstructured":"Molendijk ML, de Kloet ER. Immobility in the forced swim test is adaptive and does not reflect depression. Psychoneuroendocrinology 2015, 62: 389\u2013391.","journal-title":"Psychoneuroendocrinology"},{"key":"367_CR59","doi-asserted-by":"publisher","first-page":"6503162","DOI":"10.1155\/2016\/6503162","volume":"2016","author":"ER Kloet de","year":"2016","unstructured":"de Kloet ER, Molendijk ML. Coping with the forced swim stressor: towards understanding an adaptive mechanism. Neural Plast 2016, 2016: 6503162.","journal-title":"Neural Plast"}],"updated-by":[{"DOI":"10.1007\/s12264-019-00399-0","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000}}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-019-00367-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-019-00367-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,2]],"date-time":"2020-12-02T07:20:51Z","timestamp":1606893651000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-019-00367-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,21]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["367"],"URL":"https:\/\/doi.org\/10.1007\/s12264-019-00367-8","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12264-019-00399-0","asserted-by":"object"}]},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,21]]},"assertion":[{"value":"25 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2019","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the original publication, Figure\u00a04G was incorrectly published. The correct version of Figure\u00a04G is presented in this correction. This correction does not affect the conclusions of the paper.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}